Hospital Acquired Infection Control Market Size, Share, Trends, Growth Outlook

Hospital Acquired Infection Control Market is estimated to increase at a Compounded Annual Growth Rate of 5.9% CAGR over the forecast period from 2024 to 2030

The Hospital Acquired Infection Control Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products, Others), By End-User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers).

An Introduction to Hospital Acquired Infection Control Market in 2024

Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections that occur during the course of medical treatment or hospitalization and are not present or incubating at the time of admission. In 2024, hospital acquired infection control remains a top priority for healthcare facilities worldwide, as HAIs pose significant risks to patient safety, increase healthcare costs, and contribute to morbidity and mortality. Hospital-acquired infections can be caused by a wide range of pathogens, including bacteria, viruses, fungi, and multidrug-resistant organisms (MDROs), and can affect various body systems, including surgical sites, urinary tract, bloodstream, and respiratory tract. Healthcare facilities employ comprehensive infection control measures to prevent and mitigate the spread of HAIs, including hand hygiene protocols, environmental cleaning and disinfection, antimicrobial stewardship programs, and surveillance and monitoring of healthcare-associated infections. Additionally, healthcare providers adhere to strict infection prevention practices, such as the use of personal protective equipment (PPE), isolation precautions, and sterile techniques during invasive procedures, to minimize the risk of cross-contamination and transmission of infectious agents. With the emergence of antimicrobial resistance and healthcare-associated outbreaks, hospitals and healthcare organizations continue to invest in infection control infrastructure, training, and resources to strengthen their ability to prevent, detect, and respond to HAIs effectively. By implementing evidence-based practices and interdisciplinary approaches to infection prevention and control, healthcare facilities can reduce the incidence of HAIs, protect vulnerable patient populations, and promote a safe and hygienic environment for patient care.

Market Trend: Growing Emphasis on Infection Prevention in Healthcare Settings

A significant trend in the hospital-acquired infection control market is the growing emphasis on infection prevention in healthcare settings. With increasing awareness of the impact of hospital-acquired infections (HAIs) on patient outcomes, healthcare-associated costs, and antimicrobial resistance, there is a heightened focus on implementing comprehensive infection control measures in hospitals and healthcare facilities. Strategies such as hand hygiene protocols, environmental disinfection, antimicrobial stewardship, and surveillance systems are being prioritized to prevent the transmission of pathogens and reduce the incidence of HAIs. Additionally, advancements in infection control technologies, including ultraviolet (UV) disinfection systems, antimicrobial surfaces, and automated monitoring systems, are driving innovation in infection prevention practices. As healthcare providers and regulatory agencies prioritize patient safety and quality of care, the demand for effective HAI control solutions is expected to grow, driving market expansion and adoption of infection prevention technologies.

Market Driver: Rising Incidence of Healthcare-Associated Infections

A key driver fueling the hospital-acquired infection control market is the rising incidence of healthcare-associated infections (HAIs). HAIs, also known as nosocomial infections, are infections acquired by patients during their stay in a healthcare facility or as a result of healthcare interventions. Common HAIs include surgical site infections, urinary tract infections, bloodstream infections, and pneumonia, often caused by multidrug-resistant pathogens. HAIs pose significant challenges to patient safety, prolong hospital stays, increase healthcare costs, and contribute to morbidity and mortality rates. Healthcare providers are under increasing pressure to reduce HAI rates and comply with regulatory guidelines and accreditation standards. Consequently, there is a growing demand for infection control solutions and technologies that can effectively prevent, detect, and manage HAIs. As healthcare-associated infections continue to pose a threat to patient health and healthcare systems worldwide, the demand for hospital-acquired infection control products and services is expected to rise, driving market growth and investment in infection prevention strategies.

Market Opportunity: Adoption of Antimicrobial Coatings and Surfaces

A potential opportunity in the hospital-acquired infection control market lies in the adoption of antimicrobial coatings and surfaces. Antimicrobial coatings and surfaces are designed to inhibit the growth and spread of bacteria, viruses, and other pathogens on hospital equipment, furniture, and high-touch surfaces. These coatings can be applied to various surfaces, including bedrails, door handles, countertops, and medical devices, to create a protective barrier against microbial contamination. By integrating antimicrobial technologies into healthcare environments, hospitals can reduce the risk of surface-mediated transmission of pathogens and mitigate the spread of HAIs. Additionally, antimicrobial coatings offer continuous protection against microbial colonization and biofilm formation, helping to maintain clean and hygienic healthcare facilities. With the increasing prevalence of antibiotic-resistant pathogens and the growing importance of infection prevention in healthcare settings, there is a growing demand for antimicrobial coatings and surfaces as part of comprehensive HAI control strategies. By investing in antimicrobial technologies and partnering with healthcare facilities to implement infection control measures, stakeholders can capitalize on the opportunity to improve patient safety, enhance infection prevention practices, and differentiate their products in the hospital-acquired infection control market. Expanding into antimicrobial coatings and surfaces presents a strategic opportunity for market players to address evolving infection control needs, drive innovation, and contribute to the reduction of HAIs in healthcare settings.

Hospital Acquired Infection Control Market Share Analysis: Disinfectants is the fastest growing segment over the forecast period to 2030

Among the segments of the Hospital Acquired Infection Control Market, Disinfectants emerge as the fastest-growing product category. This accelerated growth is driven by several factors. Disinfectants play a critical role in preventing and controlling hospital-acquired infections (HAIs) by effectively eliminating pathogens from surfaces and medical equipment. With the increasing awareness of HAIs and the growing emphasis on infection prevention and control measures, there's a rising demand for high-quality disinfectants in healthcare settings. Moreover, the emergence of new infectious diseases and antibiotic-resistant pathogens underscores the importance of robust disinfection protocols, further driving the adoption of disinfectants. Additionally, advancements in disinfectant formulations and delivery systems, such as sprays, wipes, and fogging devices, enhance their efficacy and ease of use in diverse healthcare environments. As hospitals, ICUs, ambulatory surgical centers, and nursing homes prioritize infection control measures, the demand for disinfectants continues to surge, propelling their rapid growth in the market.

Hospital Acquired Infection Control Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across3M Company, Advanced Sterilization Products (ASP), Belimed AG, BGS Beta-Gamma-Service GmbH & Co. KG, C.B.M. S.r.l. Medical Equipment, Contec Inc, Continental Equipment Company, Ecolab Inc, Getinge AB, MATACHANA GROUP, MEDALKAN, MELAG Medizintechnik GmbH & Co. KG, Metrex Research LLC, Miele Group, MMM Group, Pal International, Reckitt Benckiser Group plc, Sotera Health Company, STERIS plc, Systec GmbH

Hospital Acquired Infection Control Market Segmentation

By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Hospital Acquired Infection Control Market Companies

3M Company
Advanced Sterilization Products (ASP)
Belimed AG
BGS Beta-Gamma-Service GmbH & Co. KG
C.B.M. S.r.l. Medical Equipment
Contec Inc
Continental Equipment Company
Ecolab Inc
Getinge AB
MATACHANA GROUP
MEDALKAN
MELAG Medizintechnik GmbH & Co. KG
Metrex Research LLC
Miele Group
MMM Group
Pal International
Reckitt Benckiser Group plc
Sotera Health Company
STERIS plc
Systec GmbH

Reasons to Buy the Hospital Acquired Infection Control Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Hospital Acquired Infection Control Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Hospital Acquired Infection Control Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Hospital Acquired Infection Control Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Hospital Acquired Infection Control Market Size Outlook, $ Million, 2021 to 2030
3.2 Hospital Acquired Infection Control Market Outlook by Type, $ Million, 2021 to 2030
3.3 Hospital Acquired Infection Control Market Outlook by Product, $ Million, 2021 to 2030
3.4 Hospital Acquired Infection Control Market Outlook by Application, $ Million, 2021 to 2030
3.5 Hospital Acquired Infection Control Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Hospital Acquired Infection Control Industry
4.2 Key Market Trends in Hospital Acquired Infection Control Industry
4.3 Potential Opportunities in Hospital Acquired Infection Control Industry
4.4 Key Challenges in Hospital Acquired Infection Control Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Hospital Acquired Infection Control Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Hospital Acquired Infection Control Market Outlook by Segments
7.1 Hospital Acquired Infection Control Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers

8 North America Hospital Acquired Infection Control Market Analysis and Outlook To 2030
8.1 Introduction to North America Hospital Acquired Infection Control Markets in 2024
8.2 North America Hospital Acquired Infection Control Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Hospital Acquired Infection Control Market size Outlook by Segments, 2021-2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers

9 Europe Hospital Acquired Infection Control Market Analysis and Outlook To 2030
9.1 Introduction to Europe Hospital Acquired Infection Control Markets in 2024
9.2 Europe Hospital Acquired Infection Control Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Hospital Acquired Infection Control Market Size Outlook by Segments, 2021-2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers

10 Asia Pacific Hospital Acquired Infection Control Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Hospital Acquired Infection Control Markets in 2024
10.2 Asia Pacific Hospital Acquired Infection Control Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Hospital Acquired Infection Control Market size Outlook by Segments, 2021-2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers

11 South America Hospital Acquired Infection Control Market Analysis and Outlook To 2030
11.1 Introduction to South America Hospital Acquired Infection Control Markets in 2024
11.2 South America Hospital Acquired Infection Control Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Hospital Acquired Infection Control Market size Outlook by Segments, 2021-2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers
12 Middle East and Africa Hospital Acquired Infection Control Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Hospital Acquired Infection Control Markets in 2024
12.2 Middle East and Africa Hospital Acquired Infection Control Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Hospital Acquired Infection Control Market size Outlook by Segments, 2021-2030
By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
3M Company
Advanced Sterilization Products (ASP)
Belimed AG
BGS Beta-Gamma-Service GmbH & Co. KG
C.B.M. S.r.l. Medical Equipment
Contec Inc
Continental Equipment Company
Ecolab Inc
Getinge AB
MATACHANA GROUP
MEDALKAN
MELAG Medizintechnik GmbH & Co. KG
Metrex Research LLC
Miele Group
MMM Group
Pal International
Reckitt Benckiser Group plc
Sotera Health Company
STERIS plc
Systec GmbH

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Protective Barrier
Sterilization
Disinfectants
Disinfectors
Endoscope Reprocessing Products
Others
By End-User
Hospitals & ICUs
Ambulatory Surgical & Diagnostic Centers
Nursing Homes & Maternity Centers
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)